The stability of an immunogen against enzymatic degradation is considered an important factor for the design of synthetic vaccines. For our studies, we have selected an epitope from the tandemrepeat unit of the high-molecular-weight MUC2 mucin glycoprotein, which can be underglycosylated in case of colon cancer. In this study, we prepared a MUC2 peptide containing the PTGTQ epitope of a MUC2 protein backbone-specific mAb 996 and its derivatives. In these peptides, the N-and C-terminal flanking regions were systematically substituted by up to three D-amino acids. Peptides prepared by solid-phase synthesis were tested for their mAb 996 binding in competitive ELISA experiments, and their stability was studied in serum and lysosomal preparation. Our data show that the epitope function of peptide 15 TPTPTGTQTPT 25 is retained even in the presence of two D-amino acid residues at its N-terminal flanking region and up to three at its C-terminal flanking region (tpTPTGTQtpt). Also, this partly D peptide shows high resistance against proteolytic degradation in diluted human serum and in lysosomal preparation. These findings suggest that, by appropriate combination of structural modifications (namely, D-amino acid substitution) in the flanks of an Ab epitope, it is feasible to construct a synthetic antigen with preserved recognition properties and high stability against enzymatic degradation. Peptides tPTPTGTQTpt and tpTPTGTQTpt derived from this study can be used for immunization experiments and as potential components of synthetic vaccines for tumor therapy.human serum ͉ rat liver lysosome preparation T he design of appropriate immunogen and its delivery, among other factors (e.g., schedule and route of immunization), are essential for the development of an effective peptide-based subunit vaccine. A major problem limiting the use of peptides is their instability, which is mainly due to the rapid degradation in vivo by proteases. There are different approached for protecting biologically active peptides from enzymatic decomposition, such as alteration of the amide bond (1), cyclization, conjugation to carrier molecule (2), and incorporation of nonproteinogenic amino acids such as -Ala (3) or D-amino acids (4, 5).Sela and Zisman (as reviewed in ref. 6) clearly demonstrated that the presence of D-amino acid residues in linear and multichain polypeptide antigens could improve their stability to proteolysis and alter the biological half-life but also influence B or T cell immunrecognition. The D-amino acids were incorporated into epitope peptides mainly to investigate their effect on peptide-specific B cell and͞or T cell immunogenicity and͞or to analyze the fine specificity and cross-reactivity of Abs͞T cells induced by the all-L, all-D peptides (7). Correlation between the characteristics of immune response and extended biological half-life, as well as their stability to proteolysis, were described (8-10). However, most of the available literature reports on peptides in which all L-amino acid residues were replaced by their...
BackgroundAutoreactive B cells are crucial players in the pathogenesis of rheumatoid arthritis (RA). Autoantibodies specific for citrullinated proteins (ACPA), present in the serum of approximately 60–70 % of patients, have a pathogenic role in the disease. B cell depleting therapies may result in a transient immunosuppression, increasing the risk of infections. Our aim was to develop a new therapeutic approach to selectively deplete the ACPA producing autoreactive B cells.MethodsTo target B cells synthetic citrullinated peptide derived from the β chain of fibrin, β60-74Cit 60,72,74 (β60-74Cit), the predominant epitope recognized by ACPA was used. Complement dependent cytotoxicity (CDC) was induced by a modified peptide derived from gp120 of HIV-1. To trigger CDC both the targeting peptide and the complement activating peptide were covalently coupled in multiple copies to the surface of poly (DL-lactic-co-glycolic acid) nanoparticles (NPs). Ex vivo antibody synthesis was examined by ELISA and ELISpot. CDC was tested after dead cell staining by flow cytometry.ResultsThe β60-74Cit peptide was selectively recognized by a small subset of B cells from RA patients having high level of peptide specific serum antibody, suggesting that the peptide can target diseased B cells. The modified gp120 peptide covalently coupled to NPs induced the formation of the complement membrane attack complex, C5b-9 in human serum. We show here for the first time that bifunctional NPs coupled to multiple copies of both the targeting peptide and the complement activating effector peptide on their surface significantly reduce β60-74Cit peptide specific ex vivo ACPA production, by inducing complement dependent lysis of the citrullinated peptide specific B cells of seropositive RA patients.ConclusionsBifunctional NPs covalently coupled to autoantigen epitope peptide and to a lytic peptide activating complement may specifically target and deplete the peptide specific autoreactive B-cells.
Growing evidence suggests that anti-Hsp60 antibodies might be involved in the pathogenesis of different autoimmune diseases. Attempts were reported also on the characterization of epitope specificity of anti-Hsp60 antibodies in different infectious and autoimmune diseases. However, there is a lack of data on the occurrence and epitope specificity of anti-Hsp60 antibodies in the healthy human antibody repertoire. Therefore, the aim of our study was to demonstrate the presence of anti-Hsp60 antibodies and to investigate the epitope specificity of these antibodies using a large set of synthetic 10 mer peptides covering regions of Hsp60 with high probability of antigenicity. Here we report the identification of several linear epitopes using serum Ig (IVIG) and sera from healthy subjects by ELISA assay. We have identified two epitopes 'specific' for human Hsp60 and two different epitopes 'specific' for Hsp65. In addition, six epitopes were cross-reactive in nature, detected on both proteins. The presence of these 'specific' epitopes may explain the differences in epitope structure between Hsp60 and Hsp65 observed earlier in patients with cardiovascular disease. The binding of the IVIG preparation to Hsp60 epitopes might indicate that anti-Hsp60 autoantibodies are present in the healthy human natural autoantibody repertoire.
We found that the citrulline effect is very pronounced and could be used as a complementary tool for the confirmation of modification sites in addition to losses of isocyanic acids from the protonated molecules or from fragment ions. Low collision energy applied to peptide ions having partially mobile protons reveals the site of modification by generating specific and intensive fragments of the sequence. On the other hand, fragmenting precursor ions with mobile protons usually allows full sequence coverage, although citrulline-specific fragments may exhibit lower intensities compared to other fragments.
Tandem
mass spectrometry is an indispensable tool in proteomics
used for protein sequencing and quantitation. On the basis of the
sequential fragments usually generated from peptide ions via collision-induced
dissociation, electron-transfer dissociation, or a combination of
the two, probabilistic database search engines could be used for the
identification of the peptides. The correct localization of posttranslational
modifications (PTMs) poses a more challenging problem than the general
identification of proteins. Histones are involved in the regulation
of DNA transcription via the wealth of PTMs on their N-terminal tail.
In this study, we analyzed the histone H4 peptide SGRGK incorporating
four different posttranslational modifications: citrullination, acetylation,
phosphorylation, and arginine methylation at various positions. The
pentapeptides model the enzymatic cleavage of the N-terminal tail
of human histone H4 protein by LysC protease. Fragmentation of the
peptides was investigated using higher-energy collisional dissociation
(HCD), electron-transfer dissociation (ETD), and electron-transfer
higher-energy collisional dissociation (EThcD) on an ultrahigh resolution
and mass accuracy instrument. We found that while all three techniques
have their unique characteristics, advantages, and pitfalls, EThcD
generated the most fragment ion-rich spectra. Despite potential ambiguities
regarding exact fragment identities, full sequence coverage and PTM
mapping may also be achievable. We also found novel neutral losses
from the charge-reduced precursors characteristic to citrullination
in ETD and EThcD which may be used in proteomic applications. N-Terminal
acetylation and arginine methylation could also be confirmed by their
characteristic neutral losses from the charge-reduced precursors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.